Number of items: 4.
2022
Perovic, Vladimir ,
Sabol, Ivan ,
Grce, Magdalena ,
Inngjerdingen, Marit,
Pulanic, Drazen,
Peric, Zinaida,
Peczynski, Christophe ,
Polge, Emmanuelle ,
Koenecke, Christian ,
Dickinson, Anne,
Greinix, Hildegard,
Basak, Grzegorz,
Penack, Olaf ,
Scherwath, Angela,
Barata, Anna,
Olivieri, Attilio,
Lawitschka, Anita,
Mensah-Glanowska, Patrycja,
Andrikovics, Hajnalka,
Schoemans, Helene and
Wolff, Daniel
(2022)
Practice patterns in chronic graft-versus-host disease patient management and patient reported outcome measures across the EBMT allogeneic transplantation network.
Bone Marrow Transplantation 57, pp. 1458-1460.
2021
Herrmann, Anne ,
Parisek, Mira,
Loss, Julika,
Holler, Ernst,
Barata, Anna,
Weber, Daniela,
Edinger, Matthias,
Wolff, Daniel and
Schoemans, Helene
(2021)
“This Graft-vs.-Host Disease Determines My Life. That's It.”—A Qualitative Analysis of the Experiences and Needs of Allogenic Hematopoietic Stem Cells Transplantation Survivors in Germany.
Frontiers in Public Health 2021 (9), p. 687675.
(Submitted)
Pidala, Joseph,
Kitko, Carrie,
Lee, Stephanie J.,
Carpenter, Paul,
Cuvelier, Geoffrey D.E.,
Holtan, Shernan ,
Flowers, Mary E.,
Cutler, Corey,
Jagasia, Madan,
Gooley, Ted,
Palmer, Joycelynne,
Randolph, Tim,
Levine, John E.,
Ayuk, Francis,
Dignan, Fiona,
Schoemans, Helene,
Tkaczyk, Eric ,
Farhadfar, Nosha,
Lawitschka, Anita,
Schultz, Kirk R.,
Martin, Paul J.,
Sarantopoulos, Stefanie,
Inamoto, Yoshihiro,
Socie, Gerard,
Wolff, Daniel,
Blazar, Bruce,
Greinix, Hildegard,
Paczesny, Sophie,
Pavletic, Steven and
Hill, Geoffrey
(2021)
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIb. The 2020 Preemptive Therapy Working Group Report.
Transplantation and Cellular Therapy 27 (8), pp. 632-641.
Fulltext not available.
2020
Wolff, Daniel,
Bardak, Jelena,
Edinger, Matthias,
Klinger-Schindler, Ursula,
Holler, Ernst ,
Lawitschka, Anita ,
Schoemans, Helene,
Herr, Wolfgang,
Kröger, Nikolaus and
Ayuk Ayuketang, Francis
(2020)
Evaluation of the Cost of Survivorship Care After Allogeneic Hematopoeitic Stem Cell Transplantation–An Analysis of 2 German Transplantation Centers.
Frontiers in Public Health 8 (572470), pp. 1-8.
This list was generated on Thu Nov 7 07:49:48 2024 CET.